Placental mesenchymal dysplasia: diagnostic and management insights from a case report and literature review. [PDF]
Luo Q +5 more
europepmc +1 more source
Early maternal obesity shapes offspring development through immune mechanisms: a systematized review. [PDF]
Zhang J +5 more
europepmc +1 more source
Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing. [PDF]
Bowman CJ +11 more
europepmc +1 more source
Ferroptosis and Its Emerging Role in Gestational Diabetes Mellitus
Ferroptosis contributes to the development of gestational diabetes mellitus (GDM) through iron overload, lipid peroxidation, and antioxidant system disruption. These changes impair adipocyte and β‐cell function, promoting insulin resistance and hyperglycemia.
Jinfeng Xu +4 more
wiley +1 more source
Cord insertion anomalies and adverse pregnancy outcomes: more than an incidental finding. [PDF]
Süt H, Koçar M, Yıldız GA.
europepmc +1 more source
Histiocytosis development and clinical variation through the lens of genomics
Abstract Histiocytic neoplasms are rare haematologic diseases characterised by clonal expansions of cells with a monocyte, macrophage or dendritic cell phenotype. Their clinical manifestations are diverse, ranging from indolent lesions to aggressive systemic disease.
Paul G Kemps +3 more
wiley +1 more source
Management and outcomes of heterotopic cesarean scar pregnancies: a single-center retrospective case series. [PDF]
Li C, Chen W, Xu H, Luo H.
europepmc +1 more source
Hemophilia A: An Ideal Disease for Prenatal Therapy
ABSTRACT Hemophilia A (HA) is the most common inherited coagulation defect. Current state‐of‐the‐art treatment consists of frequent administration of prophylactic infusions of coagulation factor VIII (FVIII) protein or bispecific antibodies that replace the cofactor function of FVIIIa to maintain hemostasis. However, these treatments are far from ideal,
Christopher D. Porada +2 more
wiley +1 more source
Beyond traditional models: microfluidic technologies for engineering the human placenta <i>in vitro</i>. [PDF]
Masserdotti A +9 more
europepmc +1 more source

